PILLOWPOSITIVE CERVICAL PILLOW

K990871 · Lifesleep Systems, Inc. · MYB · Jun 10, 1999 · Dental

Device Facts

Record IDK990871
Device NamePILLOWPOSITIVE CERVICAL PILLOW
ApplicantLifesleep Systems, Inc.
Product CodeMYB · Dental
Decision DateJun 10, 1999
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 872.5570
Device ClassClass 2
AttributesTherapeutic

Intended Use

PillowPositive Cervical Pillow ("PillowPositive") is intended for the reduction of symptoms (apnea/hypopnea) associated with mild obstructive sleep apnea by maintaining an open upper airway during sleep.

Device Story

PillowPositive is a cervical pillow designed to reduce symptoms of mild obstructive sleep apnea. It functions by positioning the user's head and neck in a manner similar to cardiopulmonary resuscitation (CPR) to maintain an open upper airway during sleep. The device features a thin central area for supine sleeping and two thicker, sloped side panels with earwells for side sleeping. It is intended for use by patients with mild obstructive sleep apnea to reduce the incidence of apneas and hypopneas. Clinical efficacy is demonstrated by a reduction in the Respiratory Disturbance Index.

Clinical Evidence

Evidence includes a pilot study and a pivotal study assessing the reduction of symptoms in patients with mild obstructive sleep apnea. Both studies demonstrated a statistically significant reduction in the Respiratory Disturbance Index (apneas and hypopneas) in subjects using the PillowPositive.

Technological Characteristics

Constructed of a high resiliency urethane foundation, memory foam support, and a stretch terry-cloth cover. Features a thin central section for supine sleeping and two sloped side panels with earwells for side sleeping. Includes removable foam inserts. Mechanical device; no energy source or software.

Indications for Use

Indicated for the reduction of symptoms (apneas and hypopneas) associated with mild obstructive sleep apnea.

Regulatory Classification

Identification

Intraoral devices for snoring and intraoral devices for snoring and obstructive sleep apnea are devices that are worn during sleep to reduce the incidence of snoring and to treat obstructive sleep apnea. The devices are designed to increase the patency of the airway and to decrease air turbulence and airway obstruction. The classification includes palatal lifting devices, tongue retaining devices, and mandibular repositioning devices.

Special Controls

*Classification.* Class II (special controls). The special control for these devices is the FDA guidance document entitled “Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA.”

Predicate Devices

Reference Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus, which is a symbol often associated with healthcare. The caduceus is depicted with three intertwined strands and a pair of wings at the top. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged in a circular pattern around the caduceus. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 NOV 2 9 2004 Life Sleep Systems, Inc. c/o Mr. Howard M. Holstein Hogan & Hartson L.L.P. 555 Thirteenth Street, N.W. Washington, D.C. 20004-1109 Re: K990871 Trade/Device Name: PillowPositive Cervical Pillow Regulation Number: 872.5570 Regulation Name: Intraoral devices for snoring and intraoral devices for snoring and obstructive sleep apnea Regulatory Class: Class II Product Code: MYB Dated: March 16, 1999 Received: March 16, 1999 Dear Mr. Holstein: This letter corrects our substantially equivalent letter of June 10, 1999 regarding the PillowPositive regulatory classification. At the time of that letter. FDA incorrectly classified the Cervical Pillow, as indicated, as an unclassified device. This device is classified under 872.5570, Intraoral devices for snoring and intraoral devices for snoring and obstructive sleep apnea. The product code will remain as MYB. We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent [{for the indications for use stated in the enclosure)] to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to continue marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely vours. A. Joseph Rosenthal A. Ralph Rosenthal, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health {2}------------------------------------------------ JUN 1 0 1999 # (990871 # 510(K) SUMMARY FOR LIFESLEEP SYSTEMS, INC.'S PILLOWPOSITIVE # Submitter's Name, Address, Telephone Number, and Contact Person LifeSleep Systems, Inc. 400 Oyster Point Boulevard Suite 112 South San Francisco, California 94080 | Contact: | Anthony A. DiTonno | |------------|-------------------------------------| | | President & Chief Executive Officer | | | LifeSleep Systems, Inc. | | Phone: | (650) 616-9933 / (650) 616-1005 | | Facsimile: | (650) 616-9930 | #### Date Prepared March 16, 1999 # Name of the Device LifeSleep PillowPositive Cervical Pillow #### Common or Usual Name Cervical Pillow #### Classification Name Truncal Orthosis Product Code IQK #### Predicate Devices Lifesleep System's Pillow Positive Cervical Pillow {3}------------------------------------------------ #### (4) Ortho-Rest Company's A-Just Right Pillow # Intended Use PillowPositive Cervical Pillow ("PillowPositive") is intended for the reduction of symptoms (apnea/hypopnea) associated with mild obstructive sleep apnea by maintaining an open upper airway during sleep. # Principles of Operation The PillowPositive places and holds the head and neck in a position that is similar to that used in cardiopulmonary resuscitation, the upper airway remains open, thereby reducing the incidence of mild obstructive sleep apnea. ## Technological Characteristics The pillow consists of a custom-fitted high resiliency urethane foundation, an overlying "memory foam" supporting the head and neck, a stretch terry-cloth cover, and removable foam inserts. The PillowPositive is comprised of a thin central area for supine sleeping and two thicker, sloped side panels with earwells for side sleeping. ## Performance Data LifeSleep sponsored a pilot study and a pivotal study to assess the PillowPositive's use in the reduction of symptoms associated with mild obstructive sleep apnea. The pilot study showed a statistically significant reduction in the Respiratory Disturbance Index (i.e., apneas and hypopneas) among subject with mild obstructive sleep apnea. The pivotal study indicated that the PillowPositive produces a statistically significant reduction in subject's Respiratory Disturbance Index, a key indicator of sleep apnea, in subjects with mild sleep apnea. #### Summary of the Basis for the Finding of Substantial Equivalence The LifeSleep PillowPositive for the reduction of the symptoms associated with mild obstructive sleep apnea has the same intended use as the Dr. Jonathan A. Parker's PM Positioner, and Adjustable PM Positioner. The Pillow Positive for the reduction of symptoms associated with mild sleep apnea has similar principles or operation as the PM Positioner, the Adjustable PM Positioner, and the A-Just Right Pillow. The PillowPositive for the reduction of symptoms associated with mild obstructive sleep apnea has the same technological characteristics as the legally marketed PillowPositive for snoring and very similar technological features as Ortho-Rest Company's A-Just Right Pillow. The minor differences between the intended use and {4}------------------------------------------------ the technological characteristics of LifeSleep's PillowPositive for the reduction of symptoms associated with mild obstructive sleep apnea and its predicate devices present no new issues of safety and effectiveness. Moreover, the clinical data demonstrate that the device reduces the symptoms (apneas/hypopneas) associated with mild obstructive sleep apnea. Therefore, the LifeSleep PillowPositive for the reduction of symptoms associated with mild obstructive sleep apnea is substantially equivalent to its legally marketed predicate devices. {5}------------------------------------------------ 510(k) Number (if known):_____________________________________________________________________________________________________________________________________________________ Device Name: LifeSleep Systems, Inc. PillowPositive Cervical Pillow Indications for Use: PillowPositive Cervical Pillow ("PillowPositive") is indicated for the reduction of symptoms (apneas and hypopneas) associated with mild obstructive sleep apnea. 1 (PLEASE DO NOT WRITE BELOW THIS LINE -- CONSINUE ON ANOTHER PAGE IF NEEDED) | Concurrence of CDRH, Office of Device Evaluation (ODE) | | |--------------------------------------------------------|---------| | (Division Sign-Off) | | | Division of Ophthalmic Devices | | | 510(k) Number | K990871 | | | 6/9/99 | Prescription Use __ (Per 21 C.F.R. 801.109) OR Over-The-Counter Use__________________________________________________________________________________________________________________________________________________________ (Optional Format 1-2-96)
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%